brand logo

Am Fam Physician. 2018;97(10):671-672

Author disclosure: No relevant financial affiliations.

Clinical Question

Is maternal obesity associated with failure of induction of labor?

Evidence-Based Answer

Pregnant women who are obese have nearly double the rate of cesarean delivery, and obesity increases the median duration of active labor by up to four hours when labor is induced. The difference in cesarean delivery rate is larger in obese primigravida patients presenting with cervical dilation of less than 1 cm. (Strength of Recommendation: B, based on a secondary analysis of a randomized controlled trial and cohort studies.)

Evidence Summary

A 2009 secondary analysis of data from a previous double-blind randomized controlled trial compared two types of vaginal prostaglandins.1 The study included 1,273 women requiring cervical ripening (Bishop score less than 5). They were stratified by body mass index (BMI) into lean, obese, and extremely obese (BMI less than 30 kg per m2, 30 to 39.9 kg per m2, and 40 kg per m2 or more, respectively). Patients were older than 17 years with singleton pregnancies of at least 36 weeks' gestation, less than four previous deliveries, and no previous cesarean deliveries. Intravaginal dinoprostone (Cervidil) or misoprostol (Cytotec) was used for cervical ripening. Rates of cesarean deliveries for any indication were 21% in the lean group, 30% in the obese group (odds ratio [OR] = 1.6; 95% confidence interval [CI], 1.2 to 2.1), and 37% in the extremely obese group (OR = 2.1; 95% CI, 1.5 to 3.5). Median duration of active labor was significantly longer in both obese groups (16 hours in obese and 19 hours in very obese, compared with 15 hours in the lean group (P < .001 for both comparisons). This was confirmed after adjusting for race, parity, and type of prostaglandin used.

A 2015 retrospective cohort study of 7,543 women with singleton term pregnancies undergoing labor induction examined the association between BMI and cesarean delivery rate.2 Indications for induction were classified as maternal, fetoplacental, postdates, rupture of membranes, or other. The method of induction varied. Patients were stratified into normal weight, over-weight, and obese (BMI less than 25 kg per m2, 25 to 29.9 kg per m2, and 30 kg per m2 or more, respectively). Compared with patients with normal weight, a significantly higher number of overweight and obese women had cesarean delivery (25%, 31%, and 37%, respectively; P < .001). Failure to progress was the major indication for cesarean delivery in each of the groups. The higher rate of cesarean delivery in women with elevated BMI was more pronounced when parity and cervical dilation on admission were considered. The rate of cesarean delivery in obese primigravida patients was 54% overall and 45% in those who presented with cervical dilation of 1 cm or less on admission. When all three of these risk factors were present, the cesarean delivery rate was 61%.

In 2013, a large prospective cohort study in Ireland assessed labor induction in 2,000 white women without diabetes mellitus who had varying BMIs.3 Common indications for induction were postdates, prolonged rupture of membranes, gestational diabetes, and preeclampsia. Bishop scores were not reported, but prostaglandins were administered if the cervix was unfavorable, and amniotomy was performed when the cervix was favorable. Oxytocin was added if necessary. Compared with primigravida women with normal BMIs, obese primigravida patients were nearly twice as likely to require a cesarean delivery (20% vs. 35%; P < .006.) There was no apparent difference in cesarean delivery rates when comparing multigravida women.

Help Desk Answers provides answers to questions submitted by practicing family physicians to the Family Physicians Inquiries Network (FPIN). Members of the network select questions based on their relevance to family medicine. Answers are drawn from an approved set of evidence-based resources and undergo peer review. The strength of recommendations and the level of evidence for individual studies are rated using criteria developed by the Evidence-Based Medicine Working Group (https://www.cebm.net).

The complete database of evidence-based questions and answers is copyrighted by FPIN. If interested in submitting questions or writing answers for this series, go to https://www.fpin.org or email: questions@fpin.org.

This series is coordinated by John E. Delzell Jr., MD, MSPH, associate medical editor.

A collection of FPIN’s Help Desk Answers published in AFP is available at https://www.aafp.org/afp/hda.

Continue Reading


More in AFP

More in PubMed

Copyright © 2018 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.